nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—CYP3A4—Bexarotene—hematologic cancer	0.0285	0.0829	CbGbCtD
Estazolam—CYP3A4—Lomustine—hematologic cancer	0.0265	0.0771	CbGbCtD
Estazolam—CYP3A4—Busulfan—hematologic cancer	0.0265	0.0771	CbGbCtD
Estazolam—CYP3A4—Thiotepa—hematologic cancer	0.0236	0.0687	CbGbCtD
Estazolam—CYP3A4—Methoxsalen—hematologic cancer	0.0183	0.0534	CbGbCtD
Estazolam—CYP3A4—Bortezomib—hematologic cancer	0.0174	0.0508	CbGbCtD
Estazolam—CYP3A4—Daunorubicin—hematologic cancer	0.0167	0.0486	CbGbCtD
Estazolam—CYP3A4—Cytarabine—hematologic cancer	0.0147	0.0429	CbGbCtD
Estazolam—CYP3A4—Teniposide—hematologic cancer	0.0145	0.0422	CbGbCtD
Estazolam—CYP3A4—Ifosfamide—hematologic cancer	0.0134	0.039	CbGbCtD
Estazolam—CYP3A4—Imatinib—hematologic cancer	0.0128	0.0372	CbGbCtD
Estazolam—CYP3A4—Ruxolitinib—hematologic cancer	0.012	0.0351	CbGbCtD
Estazolam—CYP3A4—Nilotinib—hematologic cancer	0.0116	0.0338	CbGbCtD
Estazolam—CYP3A4—Vinorelbine—hematologic cancer	0.0115	0.0335	CbGbCtD
Estazolam—CYP3A4—Triamcinolone—hematologic cancer	0.0105	0.0307	CbGbCtD
Estazolam—CYP3A4—Dasatinib—hematologic cancer	0.0103	0.0299	CbGbCtD
Estazolam—CYP3A4—Mitoxantrone—hematologic cancer	0.0101	0.0295	CbGbCtD
Estazolam—CYP3A4—Betamethasone—hematologic cancer	0.00904	0.0263	CbGbCtD
Estazolam—CYP3A4—Prednisolone—hematologic cancer	0.00892	0.026	CbGbCtD
Estazolam—CYP3A4—Prednisone—hematologic cancer	0.00842	0.0245	CbGbCtD
Estazolam—CYP3A4—Irinotecan—hematologic cancer	0.00799	0.0233	CbGbCtD
Estazolam—CYP3A4—Vinblastine—hematologic cancer	0.0071	0.0207	CbGbCtD
Estazolam—CYP3A4—Vincristine—hematologic cancer	0.00698	0.0203	CbGbCtD
Estazolam—CYP3A4—Etoposide—hematologic cancer	0.0064	0.0186	CbGbCtD
Estazolam—CYP3A4—Dexamethasone—hematologic cancer	0.00526	0.0153	CbGbCtD
Estazolam—CYP3A4—Doxorubicin—hematologic cancer	0.00436	0.0127	CbGbCtD
Estazolam—Flunitrazepam—UGT1A1—hematologic cancer	0.00031	0.265	CrCbGaD
Estazolam—Midazolam—SLC22A1—hematologic cancer	0.000186	0.158	CrCbGaD
Estazolam—Ketazolam—ALB—hematologic cancer	0.000117	0.1	CrCbGaD
Estazolam—Ketazolam—ABCB1—hematologic cancer	0.000112	0.0957	CrCbGaD
Estazolam—Clonazepam—ALB—hematologic cancer	9.47e-05	0.0808	CrCbGaD
Estazolam—Rash—Mitoxantrone—hematologic cancer	8.28e-05	0.000146	CcSEcCtD
Estazolam—Rash—Irinotecan—hematologic cancer	8.28e-05	0.000146	CcSEcCtD
Estazolam—Dermatitis—Mitoxantrone—hematologic cancer	8.27e-05	0.000146	CcSEcCtD
Estazolam—Dermatitis—Irinotecan—hematologic cancer	8.27e-05	0.000146	CcSEcCtD
Estazolam—Chills—Methotrexate—hematologic cancer	8.26e-05	0.000146	CcSEcCtD
Estazolam—Headache—Mitoxantrone—hematologic cancer	8.22e-05	0.000145	CcSEcCtD
Estazolam—Headache—Irinotecan—hematologic cancer	8.22e-05	0.000145	CcSEcCtD
Estazolam—Nausea—Ifosfamide—hematologic cancer	8.21e-05	0.000145	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Betamethasone—hematologic cancer	8.19e-05	0.000145	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	8.19e-05	0.000145	CcSEcCtD
Estazolam—Arthralgia—Prednisone—hematologic cancer	8.16e-05	0.000144	CcSEcCtD
Estazolam—Myalgia—Prednisone—hematologic cancer	8.16e-05	0.000144	CcSEcCtD
Estazolam—Feeling abnormal—Triamcinolone—hematologic cancer	8.16e-05	0.000144	CcSEcCtD
Estazolam—Erythema multiforme—Epirubicin—hematologic cancer	8.14e-05	0.000144	CcSEcCtD
Estazolam—Anxiety—Prednisone—hematologic cancer	8.13e-05	0.000144	CcSEcCtD
Estazolam—Vomiting—Gemcitabine—hematologic cancer	8.13e-05	0.000144	CcSEcCtD
Estazolam—Paraesthesia—Dexamethasone—hematologic cancer	8.07e-05	0.000143	CcSEcCtD
Estazolam—Paraesthesia—Betamethasone—hematologic cancer	8.07e-05	0.000143	CcSEcCtD
Estazolam—Discomfort—Prednisone—hematologic cancer	8.07e-05	0.000143	CcSEcCtD
Estazolam—Rash—Gemcitabine—hematologic cancer	8.06e-05	0.000143	CcSEcCtD
Estazolam—Dermatitis—Gemcitabine—hematologic cancer	8.05e-05	0.000142	CcSEcCtD
Estazolam—Hypersensitivity—Etoposide—hematologic cancer	8.04e-05	0.000142	CcSEcCtD
Estazolam—Tinnitus—Epirubicin—hematologic cancer	8.03e-05	0.000142	CcSEcCtD
Estazolam—Malnutrition—Methotrexate—hematologic cancer	8.01e-05	0.000142	CcSEcCtD
Estazolam—Headache—Gemcitabine—hematologic cancer	8.01e-05	0.000142	CcSEcCtD
Estazolam—Nausea—Vincristine—hematologic cancer	8.01e-05	0.000142	CcSEcCtD
Estazolam—Flushing—Epirubicin—hematologic cancer	7.99e-05	0.000141	CcSEcCtD
Estazolam—Rhinitis—Doxorubicin—hematologic cancer	7.99e-05	0.000141	CcSEcCtD
Estazolam—Hypersensitivity—Prednisolone—hematologic cancer	7.93e-05	0.00014	CcSEcCtD
Estazolam—Clobazam—ABCB1—hematologic cancer	7.92e-05	0.0676	CrCbGaD
Estazolam—Pharyngitis—Doxorubicin—hematologic cancer	7.91e-05	0.00014	CcSEcCtD
Estazolam—Dyspepsia—Dexamethasone—hematologic cancer	7.91e-05	0.00014	CcSEcCtD
Estazolam—Dyspepsia—Betamethasone—hematologic cancer	7.91e-05	0.00014	CcSEcCtD
Estazolam—Urticaria—Triamcinolone—hematologic cancer	7.87e-05	0.000139	CcSEcCtD
Estazolam—Asthenia—Etoposide—hematologic cancer	7.83e-05	0.000139	CcSEcCtD
Estazolam—Body temperature increased—Triamcinolone—hematologic cancer	7.83e-05	0.000138	CcSEcCtD
Estazolam—Oedema—Prednisone—hematologic cancer	7.83e-05	0.000138	CcSEcCtD
Estazolam—Decreased appetite—Betamethasone—hematologic cancer	7.81e-05	0.000138	CcSEcCtD
Estazolam—Decreased appetite—Dexamethasone—hematologic cancer	7.81e-05	0.000138	CcSEcCtD
Estazolam—Nausea—Irinotecan—hematologic cancer	7.8e-05	0.000138	CcSEcCtD
Estazolam—Nausea—Mitoxantrone—hematologic cancer	7.8e-05	0.000138	CcSEcCtD
Estazolam—Back pain—Methotrexate—hematologic cancer	7.75e-05	0.000137	CcSEcCtD
Estazolam—Chills—Epirubicin—hematologic cancer	7.73e-05	0.000137	CcSEcCtD
Estazolam—Pruritus—Etoposide—hematologic cancer	7.72e-05	0.000137	CcSEcCtD
Estazolam—Shock—Prednisone—hematologic cancer	7.7e-05	0.000136	CcSEcCtD
Estazolam—Arrhythmia—Epirubicin—hematologic cancer	7.7e-05	0.000136	CcSEcCtD
Estazolam—Pain—Dexamethasone—hematologic cancer	7.68e-05	0.000136	CcSEcCtD
Estazolam—Pain—Betamethasone—hematologic cancer	7.68e-05	0.000136	CcSEcCtD
Estazolam—Visual impairment—Doxorubicin—hematologic cancer	7.68e-05	0.000136	CcSEcCtD
Estazolam—Nausea—Gemcitabine—hematologic cancer	7.59e-05	0.000134	CcSEcCtD
Estazolam—Vomiting—Cisplatin—hematologic cancer	7.58e-05	0.000134	CcSEcCtD
Estazolam—Hyperhidrosis—Prednisone—hematologic cancer	7.56e-05	0.000134	CcSEcCtD
Estazolam—Erythema multiforme—Doxorubicin—hematologic cancer	7.54e-05	0.000133	CcSEcCtD
Estazolam—Rash—Cisplatin—hematologic cancer	7.51e-05	0.000133	CcSEcCtD
Estazolam—Dermatitis—Cisplatin—hematologic cancer	7.51e-05	0.000133	CcSEcCtD
Estazolam—Malnutrition—Epirubicin—hematologic cancer	7.5e-05	0.000133	CcSEcCtD
Estazolam—Ill-defined disorder—Methotrexate—hematologic cancer	7.43e-05	0.000131	CcSEcCtD
Estazolam—Tinnitus—Doxorubicin—hematologic cancer	7.43e-05	0.000131	CcSEcCtD
Estazolam—Feeling abnormal—Betamethasone—hematologic cancer	7.4e-05	0.000131	CcSEcCtD
Estazolam—Feeling abnormal—Dexamethasone—hematologic cancer	7.4e-05	0.000131	CcSEcCtD
Estazolam—Flushing—Doxorubicin—hematologic cancer	7.4e-05	0.000131	CcSEcCtD
Estazolam—Flatulence—Epirubicin—hematologic cancer	7.39e-05	0.000131	CcSEcCtD
Estazolam—Tension—Epirubicin—hematologic cancer	7.36e-05	0.00013	CcSEcCtD
Estazolam—Gastrointestinal pain—Betamethasone—hematologic cancer	7.35e-05	0.00013	CcSEcCtD
Estazolam—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.35e-05	0.00013	CcSEcCtD
Estazolam—Hypersensitivity—Triamcinolone—hematologic cancer	7.3e-05	0.000129	CcSEcCtD
Estazolam—Nervousness—Epirubicin—hematologic cancer	7.28e-05	0.000129	CcSEcCtD
Estazolam—Back pain—Epirubicin—hematologic cancer	7.25e-05	0.000128	CcSEcCtD
Estazolam—Malaise—Methotrexate—hematologic cancer	7.23e-05	0.000128	CcSEcCtD
Estazolam—Dizziness—Etoposide—hematologic cancer	7.22e-05	0.000128	CcSEcCtD
Estazolam—Muscle spasms—Epirubicin—hematologic cancer	7.21e-05	0.000127	CcSEcCtD
Estazolam—Leukopenia—Methotrexate—hematologic cancer	7.17e-05	0.000127	CcSEcCtD
Estazolam—Chills—Doxorubicin—hematologic cancer	7.15e-05	0.000126	CcSEcCtD
Estazolam—Urticaria—Dexamethasone—hematologic cancer	7.14e-05	0.000126	CcSEcCtD
Estazolam—Urticaria—Betamethasone—hematologic cancer	7.14e-05	0.000126	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.13e-05	0.000126	CcSEcCtD
Estazolam—Dizziness—Prednisolone—hematologic cancer	7.12e-05	0.000126	CcSEcCtD
Estazolam—Arrhythmia—Doxorubicin—hematologic cancer	7.12e-05	0.000126	CcSEcCtD
Estazolam—Asthenia—Triamcinolone—hematologic cancer	7.11e-05	0.000126	CcSEcCtD
Estazolam—Abdominal pain—Betamethasone—hematologic cancer	7.1e-05	0.000126	CcSEcCtD
Estazolam—Body temperature increased—Dexamethasone—hematologic cancer	7.1e-05	0.000126	CcSEcCtD
Estazolam—Abdominal pain—Dexamethasone—hematologic cancer	7.1e-05	0.000126	CcSEcCtD
Estazolam—Body temperature increased—Betamethasone—hematologic cancer	7.1e-05	0.000126	CcSEcCtD
Estazolam—Nausea—Cisplatin—hematologic cancer	7.08e-05	0.000125	CcSEcCtD
Estazolam—Paraesthesia—Prednisone—hematologic cancer	7.03e-05	0.000124	CcSEcCtD
Estazolam—Pruritus—Triamcinolone—hematologic cancer	7.01e-05	0.000124	CcSEcCtD
Estazolam—Cough—Methotrexate—hematologic cancer	6.99e-05	0.000124	CcSEcCtD
Estazolam—Ill-defined disorder—Epirubicin—hematologic cancer	6.96e-05	0.000123	CcSEcCtD
Estazolam—Convulsion—Methotrexate—hematologic cancer	6.94e-05	0.000123	CcSEcCtD
Estazolam—Vomiting—Etoposide—hematologic cancer	6.94e-05	0.000123	CcSEcCtD
Estazolam—Malnutrition—Doxorubicin—hematologic cancer	6.94e-05	0.000123	CcSEcCtD
Estazolam—Agitation—Epirubicin—hematologic cancer	6.89e-05	0.000122	CcSEcCtD
Estazolam—Dyspepsia—Prednisone—hematologic cancer	6.89e-05	0.000122	CcSEcCtD
Estazolam—Rash—Etoposide—hematologic cancer	6.88e-05	0.000122	CcSEcCtD
Estazolam—Dermatitis—Etoposide—hematologic cancer	6.88e-05	0.000122	CcSEcCtD
Estazolam—Headache—Etoposide—hematologic cancer	6.84e-05	0.000121	CcSEcCtD
Estazolam—Flatulence—Doxorubicin—hematologic cancer	6.84e-05	0.000121	CcSEcCtD
Estazolam—Arthralgia—Methotrexate—hematologic cancer	6.82e-05	0.000121	CcSEcCtD
Estazolam—Myalgia—Methotrexate—hematologic cancer	6.82e-05	0.000121	CcSEcCtD
Estazolam—Chest pain—Methotrexate—hematologic cancer	6.82e-05	0.000121	CcSEcCtD
Estazolam—Tension—Doxorubicin—hematologic cancer	6.81e-05	0.00012	CcSEcCtD
Estazolam—Decreased appetite—Prednisone—hematologic cancer	6.8e-05	0.00012	CcSEcCtD
Estazolam—Rash—Prednisolone—hematologic cancer	6.79e-05	0.00012	CcSEcCtD
Estazolam—Dermatitis—Prednisolone—hematologic cancer	6.78e-05	0.00012	CcSEcCtD
Estazolam—Malaise—Epirubicin—hematologic cancer	6.76e-05	0.00012	CcSEcCtD
Estazolam—Headache—Prednisolone—hematologic cancer	6.75e-05	0.000119	CcSEcCtD
Estazolam—Discomfort—Methotrexate—hematologic cancer	6.74e-05	0.000119	CcSEcCtD
Estazolam—Nervousness—Doxorubicin—hematologic cancer	6.74e-05	0.000119	CcSEcCtD
Estazolam—Syncope—Epirubicin—hematologic cancer	6.72e-05	0.000119	CcSEcCtD
Estazolam—Leukopenia—Epirubicin—hematologic cancer	6.71e-05	0.000119	CcSEcCtD
Estazolam—Back pain—Doxorubicin—hematologic cancer	6.71e-05	0.000119	CcSEcCtD
Estazolam—Constipation—Prednisone—hematologic cancer	6.69e-05	0.000118	CcSEcCtD
Estazolam—Muscle spasms—Doxorubicin—hematologic cancer	6.67e-05	0.000118	CcSEcCtD
Estazolam—Palpitations—Epirubicin—hematologic cancer	6.63e-05	0.000117	CcSEcCtD
Estazolam—Confusional state—Methotrexate—hematologic cancer	6.59e-05	0.000117	CcSEcCtD
Estazolam—Loss of consciousness—Epirubicin—hematologic cancer	6.59e-05	0.000117	CcSEcCtD
Estazolam—Dizziness—Triamcinolone—hematologic cancer	6.55e-05	0.000116	CcSEcCtD
Estazolam—Nitrazepam—ABCB1—hematologic cancer	6.55e-05	0.0559	CrCbGaD
Estazolam—Cough—Epirubicin—hematologic cancer	6.54e-05	0.000116	CcSEcCtD
Estazolam—Convulsion—Epirubicin—hematologic cancer	6.5e-05	0.000115	CcSEcCtD
Estazolam—Nausea—Etoposide—hematologic cancer	6.49e-05	0.000115	CcSEcCtD
Estazolam—Feeling abnormal—Prednisone—hematologic cancer	6.45e-05	0.000114	CcSEcCtD
Estazolam—Asthenia—Betamethasone—hematologic cancer	6.45e-05	0.000114	CcSEcCtD
Estazolam—Asthenia—Dexamethasone—hematologic cancer	6.45e-05	0.000114	CcSEcCtD
Estazolam—Ill-defined disorder—Doxorubicin—hematologic cancer	6.44e-05	0.000114	CcSEcCtD
Estazolam—Gastrointestinal pain—Prednisone—hematologic cancer	6.4e-05	0.000113	CcSEcCtD
Estazolam—Nausea—Prednisolone—hematologic cancer	6.4e-05	0.000113	CcSEcCtD
Estazolam—Chest pain—Epirubicin—hematologic cancer	6.38e-05	0.000113	CcSEcCtD
Estazolam—Arthralgia—Epirubicin—hematologic cancer	6.38e-05	0.000113	CcSEcCtD
Estazolam—Myalgia—Epirubicin—hematologic cancer	6.38e-05	0.000113	CcSEcCtD
Estazolam—Agitation—Doxorubicin—hematologic cancer	6.38e-05	0.000113	CcSEcCtD
Estazolam—Anxiety—Epirubicin—hematologic cancer	6.36e-05	0.000113	CcSEcCtD
Estazolam—Pruritus—Dexamethasone—hematologic cancer	6.36e-05	0.000112	CcSEcCtD
Estazolam—Pruritus—Betamethasone—hematologic cancer	6.36e-05	0.000112	CcSEcCtD
Estazolam—Hyperhidrosis—Methotrexate—hematologic cancer	6.32e-05	0.000112	CcSEcCtD
Estazolam—Discomfort—Epirubicin—hematologic cancer	6.31e-05	0.000112	CcSEcCtD
Estazolam—Vomiting—Triamcinolone—hematologic cancer	6.3e-05	0.000111	CcSEcCtD
Estazolam—Malaise—Doxorubicin—hematologic cancer	6.26e-05	0.000111	CcSEcCtD
Estazolam—Rash—Triamcinolone—hematologic cancer	6.24e-05	0.00011	CcSEcCtD
Estazolam—Dry mouth—Epirubicin—hematologic cancer	6.24e-05	0.00011	CcSEcCtD
Estazolam—Dermatitis—Triamcinolone—hematologic cancer	6.24e-05	0.00011	CcSEcCtD
Estazolam—Syncope—Doxorubicin—hematologic cancer	6.22e-05	0.00011	CcSEcCtD
Estazolam—Urticaria—Prednisone—hematologic cancer	6.22e-05	0.00011	CcSEcCtD
Estazolam—Leukopenia—Doxorubicin—hematologic cancer	6.21e-05	0.00011	CcSEcCtD
Estazolam—Headache—Triamcinolone—hematologic cancer	6.2e-05	0.00011	CcSEcCtD
Estazolam—Abdominal pain—Prednisone—hematologic cancer	6.19e-05	0.000109	CcSEcCtD
Estazolam—Body temperature increased—Prednisone—hematologic cancer	6.19e-05	0.000109	CcSEcCtD
Estazolam—Confusional state—Epirubicin—hematologic cancer	6.17e-05	0.000109	CcSEcCtD
Estazolam—Palpitations—Doxorubicin—hematologic cancer	6.13e-05	0.000108	CcSEcCtD
Estazolam—Oedema—Epirubicin—hematologic cancer	6.12e-05	0.000108	CcSEcCtD
Estazolam—Loss of consciousness—Doxorubicin—hematologic cancer	6.1e-05	0.000108	CcSEcCtD
Estazolam—Cough—Doxorubicin—hematologic cancer	6.05e-05	0.000107	CcSEcCtD
Estazolam—Shock—Epirubicin—hematologic cancer	6.02e-05	0.000106	CcSEcCtD
Estazolam—Convulsion—Doxorubicin—hematologic cancer	6.01e-05	0.000106	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.96e-05	0.000105	CcSEcCtD
Estazolam—Dizziness—Betamethasone—hematologic cancer	5.94e-05	0.000105	CcSEcCtD
Estazolam—Dizziness—Dexamethasone—hematologic cancer	5.94e-05	0.000105	CcSEcCtD
Estazolam—Hyperhidrosis—Epirubicin—hematologic cancer	5.92e-05	0.000105	CcSEcCtD
Estazolam—Arthralgia—Doxorubicin—hematologic cancer	5.91e-05	0.000104	CcSEcCtD
Estazolam—Chest pain—Doxorubicin—hematologic cancer	5.91e-05	0.000104	CcSEcCtD
Estazolam—Myalgia—Doxorubicin—hematologic cancer	5.91e-05	0.000104	CcSEcCtD
Estazolam—Anxiety—Doxorubicin—hematologic cancer	5.89e-05	0.000104	CcSEcCtD
Estazolam—Nausea—Triamcinolone—hematologic cancer	5.88e-05	0.000104	CcSEcCtD
Estazolam—Paraesthesia—Methotrexate—hematologic cancer	5.87e-05	0.000104	CcSEcCtD
Estazolam—Discomfort—Doxorubicin—hematologic cancer	5.84e-05	0.000103	CcSEcCtD
Estazolam—Dyspnoea—Methotrexate—hematologic cancer	5.83e-05	0.000103	CcSEcCtD
Estazolam—Flurazepam—ABCB1—hematologic cancer	5.82e-05	0.0497	CrCbGaD
Estazolam—Somnolence—Methotrexate—hematologic cancer	5.81e-05	0.000103	CcSEcCtD
Estazolam—Dry mouth—Doxorubicin—hematologic cancer	5.78e-05	0.000102	CcSEcCtD
Estazolam—Hypersensitivity—Prednisone—hematologic cancer	5.77e-05	0.000102	CcSEcCtD
Estazolam—Dyspepsia—Methotrexate—hematologic cancer	5.76e-05	0.000102	CcSEcCtD
Estazolam—Vomiting—Betamethasone—hematologic cancer	5.71e-05	0.000101	CcSEcCtD
Estazolam—Vomiting—Dexamethasone—hematologic cancer	5.71e-05	0.000101	CcSEcCtD
Estazolam—Confusional state—Doxorubicin—hematologic cancer	5.71e-05	0.000101	CcSEcCtD
Estazolam—Decreased appetite—Methotrexate—hematologic cancer	5.68e-05	0.000101	CcSEcCtD
Estazolam—Rash—Betamethasone—hematologic cancer	5.67e-05	0.0001	CcSEcCtD
Estazolam—Rash—Dexamethasone—hematologic cancer	5.67e-05	0.0001	CcSEcCtD
Estazolam—Oedema—Doxorubicin—hematologic cancer	5.66e-05	0.0001	CcSEcCtD
Estazolam—Dermatitis—Betamethasone—hematologic cancer	5.66e-05	0.0001	CcSEcCtD
Estazolam—Dermatitis—Dexamethasone—hematologic cancer	5.66e-05	0.0001	CcSEcCtD
Estazolam—Headache—Dexamethasone—hematologic cancer	5.63e-05	9.95e-05	CcSEcCtD
Estazolam—Headache—Betamethasone—hematologic cancer	5.63e-05	9.95e-05	CcSEcCtD
Estazolam—Asthenia—Prednisone—hematologic cancer	5.61e-05	9.93e-05	CcSEcCtD
Estazolam—Pain—Methotrexate—hematologic cancer	5.59e-05	9.89e-05	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.58e-05	9.86e-05	CcSEcCtD
Estazolam—Shock—Doxorubicin—hematologic cancer	5.57e-05	9.85e-05	CcSEcCtD
Estazolam—Pruritus—Prednisone—hematologic cancer	5.54e-05	9.79e-05	CcSEcCtD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	5.52e-05	0.000613	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MTOR—hematologic cancer	5.52e-05	0.000613	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.5e-05	0.000611	CbGpPWpGaD
Estazolam—Paraesthesia—Epirubicin—hematologic cancer	5.5e-05	9.72e-05	CcSEcCtD
Estazolam—GABRA5—Transmission across Chemical Synapses—CREB1—hematologic cancer	5.49e-05	0.000611	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—PRKCG—hematologic cancer	5.49e-05	0.00061	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—MDM2—hematologic cancer	5.48e-05	0.000609	CbGpPWpGaD
Estazolam—Hyperhidrosis—Doxorubicin—hematologic cancer	5.47e-05	9.68e-05	CcSEcCtD
Estazolam—Dyspnoea—Epirubicin—hematologic cancer	5.46e-05	9.65e-05	CcSEcCtD
Estazolam—GABRB3—Neuronal System—PRKCG—hematologic cancer	5.45e-05	0.000606	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.44e-05	0.000605	CbGpPWpGaD
Estazolam—Somnolence—Epirubicin—hematologic cancer	5.44e-05	9.62e-05	CcSEcCtD
Estazolam—GABRA5—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.43e-05	0.000604	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—BRAF—hematologic cancer	5.43e-05	0.000603	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—MDM2—hematologic cancer	5.42e-05	0.000603	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.4e-05	0.000601	CbGpPWpGaD
Estazolam—Midazolam—ABCB1—hematologic cancer	5.4e-05	0.0461	CrCbGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—CREB1—hematologic cancer	5.4e-05	0.0006	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.4e-05	0.0006	CbGpPWpGaD
Estazolam—Feeling abnormal—Methotrexate—hematologic cancer	5.39e-05	9.53e-05	CcSEcCtD
Estazolam—Dyspepsia—Epirubicin—hematologic cancer	5.39e-05	9.53e-05	CcSEcCtD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	5.38e-05	0.000598	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	5.37e-05	0.000598	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.37e-05	0.000597	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—PRKCG—hematologic cancer	5.35e-05	0.000595	CbGpPWpGaD
Estazolam—Gastrointestinal pain—Methotrexate—hematologic cancer	5.35e-05	9.46e-05	CcSEcCtD
Estazolam—Nausea—Dexamethasone—hematologic cancer	5.34e-05	9.44e-05	CcSEcCtD
Estazolam—Nausea—Betamethasone—hematologic cancer	5.34e-05	9.44e-05	CcSEcCtD
Estazolam—GABRA3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.34e-05	0.000593	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.34e-05	0.000593	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—BRAF—hematologic cancer	5.33e-05	0.000593	CbGpPWpGaD
Estazolam—Decreased appetite—Epirubicin—hematologic cancer	5.32e-05	9.41e-05	CcSEcCtD
Estazolam—GABRA2—Transmission across Chemical Synapses—CREB1—hematologic cancer	5.3e-05	0.00059	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.3e-05	0.000589	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.29e-05	0.000588	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.27e-05	0.000586	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—CREB1—hematologic cancer	5.27e-05	0.000586	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.24e-05	0.000583	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—BRAF—hematologic cancer	5.24e-05	0.000582	CbGpPWpGaD
Estazolam—Constipation—Epirubicin—hematologic cancer	5.23e-05	9.25e-05	CcSEcCtD
Estazolam—Pain—Epirubicin—hematologic cancer	5.23e-05	9.25e-05	CcSEcCtD
Estazolam—GABRB3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.21e-05	0.000579	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.21e-05	0.000579	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—BRAF—hematologic cancer	5.2e-05	0.000579	CbGpPWpGaD
Estazolam—Urticaria—Methotrexate—hematologic cancer	5.2e-05	9.19e-05	CcSEcCtD
Estazolam—GABRA3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.19e-05	0.000577	CbGpPWpGaD
Estazolam—Dizziness—Prednisone—hematologic cancer	5.17e-05	9.15e-05	CcSEcCtD
Estazolam—GABRG2—Transmission across Chemical Synapses—CREB1—hematologic cancer	5.17e-05	0.000575	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—MDM2—hematologic cancer	5.17e-05	0.000575	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.17e-05	0.000575	CbGpPWpGaD
Estazolam—Abdominal pain—Methotrexate—hematologic cancer	5.17e-05	9.14e-05	CcSEcCtD
Estazolam—Body temperature increased—Methotrexate—hematologic cancer	5.17e-05	9.14e-05	CcSEcCtD
Estazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	5.17e-05	0.000575	CbGpPWpGaD
Estazolam—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.16e-05	9.12e-05	CcSEcCtD
Estazolam—GABRG3—Neuronal System—CREB1—hematologic cancer	5.15e-05	0.000573	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	5.14e-05	0.000571	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.12e-05	0.000569	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—BRAF—hematologic cancer	5.11e-05	0.000568	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.1e-05	0.000567	CbGpPWpGaD
Estazolam—Paraesthesia—Doxorubicin—hematologic cancer	5.08e-05	8.99e-05	CcSEcCtD
Estazolam—GABRG3—Neuronal System—BRAF—hematologic cancer	5.08e-05	0.000565	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.08e-05	0.000565	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—CASP3—hematologic cancer	5.07e-05	0.000564	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—CREB1—hematologic cancer	5.07e-05	0.000564	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.07e-05	0.000564	CbGpPWpGaD
Estazolam—Dyspnoea—Doxorubicin—hematologic cancer	5.05e-05	8.93e-05	CcSEcCtD
Estazolam—Feeling abnormal—Epirubicin—hematologic cancer	5.04e-05	8.92e-05	CcSEcCtD
Estazolam—Somnolence—Doxorubicin—hematologic cancer	5.03e-05	8.9e-05	CcSEcCtD
Estazolam—GABRB1—Neuronal System—BRAF—hematologic cancer	5.01e-05	0.000557	CbGpPWpGaD
Estazolam—Gastrointestinal pain—Epirubicin—hematologic cancer	5e-05	8.85e-05	CcSEcCtD
Estazolam—Dyspepsia—Doxorubicin—hematologic cancer	4.98e-05	8.81e-05	CcSEcCtD
Estazolam—GABRG2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.98e-05	0.000553	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	4.98e-05	0.000553	CbGpPWpGaD
Estazolam—Vomiting—Prednisone—hematologic cancer	4.98e-05	8.8e-05	CcSEcCtD
Estazolam—Rash—Prednisone—hematologic cancer	4.93e-05	8.72e-05	CcSEcCtD
Estazolam—Dermatitis—Prednisone—hematologic cancer	4.93e-05	8.72e-05	CcSEcCtD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	4.93e-05	0.000548	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—JUN—hematologic cancer	4.93e-05	0.000548	CbGpPWpGaD
Estazolam—Decreased appetite—Doxorubicin—hematologic cancer	4.92e-05	8.7e-05	CcSEcCtD
Estazolam—Headache—Prednisone—hematologic cancer	4.9e-05	8.67e-05	CcSEcCtD
Estazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.9e-05	0.000545	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4.88e-05	0.000543	CbGpPWpGaD
Estazolam—Urticaria—Epirubicin—hematologic cancer	4.86e-05	8.6e-05	CcSEcCtD
Estazolam—GABRB2—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.85e-05	0.000539	CbGpPWpGaD
Estazolam—Diazepam—ALB—hematologic cancer	4.85e-05	0.0414	CrCbGaD
Estazolam—Constipation—Doxorubicin—hematologic cancer	4.84e-05	8.56e-05	CcSEcCtD
Estazolam—Pain—Doxorubicin—hematologic cancer	4.84e-05	8.56e-05	CcSEcCtD
Estazolam—Abdominal pain—Epirubicin—hematologic cancer	4.84e-05	8.56e-05	CcSEcCtD
Estazolam—Body temperature increased—Epirubicin—hematologic cancer	4.84e-05	8.56e-05	CcSEcCtD
Estazolam—GABRG3—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.84e-05	0.000538	CbGpPWpGaD
Estazolam—Hypersensitivity—Methotrexate—hematologic cancer	4.82e-05	8.52e-05	CcSEcCtD
Estazolam—GABRB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.76e-05	0.00053	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.71e-05	0.000524	CbGpPWpGaD
Estazolam—Asthenia—Methotrexate—hematologic cancer	4.69e-05	8.3e-05	CcSEcCtD
Estazolam—GABRB2—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.68e-05	0.00052	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—PRKCG—hematologic cancer	4.68e-05	0.00052	CbGpPWpGaD
Estazolam—Feeling abnormal—Doxorubicin—hematologic cancer	4.67e-05	8.25e-05	CcSEcCtD
Estazolam—GABRB3—BDNF signaling pathway—MAPK8—hematologic cancer	4.66e-05	0.000519	CbGpPWpGaD
Estazolam—Nausea—Prednisone—hematologic cancer	4.65e-05	8.22e-05	CcSEcCtD
Estazolam—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.63e-05	8.19e-05	CcSEcCtD
Estazolam—Pruritus—Methotrexate—hematologic cancer	4.63e-05	8.18e-05	CcSEcCtD
Estazolam—GABRA3—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.63e-05	0.000515	CbGpPWpGaD
Estazolam—Diazepam—ABCB1—hematologic cancer	4.62e-05	0.0395	CrCbGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.61e-05	0.000512	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.55e-05	0.000506	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.55e-05	0.000506	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—CREB1—hematologic cancer	4.52e-05	0.000503	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.52e-05	0.000502	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	4.52e-05	0.000502	CbGpPWpGaD
Estazolam—Hypersensitivity—Epirubicin—hematologic cancer	4.51e-05	7.97e-05	CcSEcCtD
Estazolam—Urticaria—Doxorubicin—hematologic cancer	4.5e-05	7.95e-05	CcSEcCtD
Estazolam—Abdominal pain—Doxorubicin—hematologic cancer	4.48e-05	7.92e-05	CcSEcCtD
Estazolam—Body temperature increased—Doxorubicin—hematologic cancer	4.48e-05	7.92e-05	CcSEcCtD
Estazolam—GABRA1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.47e-05	0.000497	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—BRAF—hematologic cancer	4.47e-05	0.000497	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.46e-05	0.000497	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	4.45e-05	0.000495	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.44e-05	0.000494	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.44e-05	0.000493	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—SRC—hematologic cancer	4.42e-05	0.000492	CbGpPWpGaD
Estazolam—Asthenia—Epirubicin—hematologic cancer	4.39e-05	7.76e-05	CcSEcCtD
Estazolam—GABRA2—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.39e-05	0.000488	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.36e-05	0.000485	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.35e-05	0.000484	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—CREB1—hematologic cancer	4.33e-05	0.000482	CbGpPWpGaD
Estazolam—Pruritus—Epirubicin—hematologic cancer	4.33e-05	7.66e-05	CcSEcCtD
Estazolam—Dizziness—Methotrexate—hematologic cancer	4.32e-05	7.65e-05	CcSEcCtD
Estazolam—GABRG2—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.28e-05	0.000476	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—BRAF—hematologic cancer	4.28e-05	0.000476	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—STAT3—hematologic cancer	4.26e-05	0.000474	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—MDM2—hematologic cancer	4.26e-05	0.000474	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	4.25e-05	0.000472	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—CREB1—hematologic cancer	4.21e-05	0.000468	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—MDM2—hematologic cancer	4.2e-05	0.000467	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	4.19e-05	0.000466	CbGpPWpGaD
Estazolam—Hypersensitivity—Doxorubicin—hematologic cancer	4.17e-05	7.38e-05	CcSEcCtD
Estazolam—Vomiting—Methotrexate—hematologic cancer	4.16e-05	7.35e-05	CcSEcCtD
Estazolam—GABRA5—Neuronal System—BRAF—hematologic cancer	4.16e-05	0.000462	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—CREB1—hematologic cancer	4.13e-05	0.00046	CbGpPWpGaD
Estazolam—Rash—Methotrexate—hematologic cancer	4.12e-05	7.29e-05	CcSEcCtD
Estazolam—Dermatitis—Methotrexate—hematologic cancer	4.12e-05	7.28e-05	CcSEcCtD
Estazolam—Headache—Methotrexate—hematologic cancer	4.1e-05	7.24e-05	CcSEcCtD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	4.09e-05	0.000455	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	4.08e-05	0.000454	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—BRAF—hematologic cancer	4.08e-05	0.000454	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MAPK3—hematologic cancer	4.07e-05	0.000453	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.07e-05	0.000453	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—CREB1—hematologic cancer	4.06e-05	0.000452	CbGpPWpGaD
Estazolam—Asthenia—Doxorubicin—hematologic cancer	4.06e-05	7.18e-05	CcSEcCtD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	4.06e-05	0.000451	CbGpPWpGaD
Estazolam—Dizziness—Epirubicin—hematologic cancer	4.05e-05	7.16e-05	CcSEcCtD
Estazolam—GABRB3—Neuronal System—CREB1—hematologic cancer	4.04e-05	0.000449	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.03e-05	0.000449	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—BRAF—hematologic cancer	4.01e-05	0.000446	CbGpPWpGaD
Estazolam—Pruritus—Doxorubicin—hematologic cancer	4.01e-05	7.08e-05	CcSEcCtD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	4e-05	0.000445	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—BRAF—hematologic cancer	3.99e-05	0.000443	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.97e-05	0.000442	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—JUN—hematologic cancer	3.97e-05	0.000441	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—CREB1—hematologic cancer	3.96e-05	0.000441	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.95e-05	0.00044	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—BRAF—hematologic cancer	3.91e-05	0.000435	CbGpPWpGaD
Estazolam—Vomiting—Epirubicin—hematologic cancer	3.89e-05	6.88e-05	CcSEcCtD
Estazolam—Nausea—Methotrexate—hematologic cancer	3.88e-05	6.87e-05	CcSEcCtD
Estazolam—GABRR1—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.88e-05	0.000432	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.88e-05	0.000432	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.88e-05	0.000431	CbGpPWpGaD
Estazolam—Rash—Epirubicin—hematologic cancer	3.86e-05	6.82e-05	CcSEcCtD
Estazolam—Dermatitis—Epirubicin—hematologic cancer	3.86e-05	6.82e-05	CcSEcCtD
Estazolam—Headache—Epirubicin—hematologic cancer	3.83e-05	6.78e-05	CcSEcCtD
Estazolam—GABRA2—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.82e-05	0.000424	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.79e-05	0.000422	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	3.75e-05	0.000417	CbGpPWpGaD
Estazolam—Dizziness—Doxorubicin—hematologic cancer	3.74e-05	6.62e-05	CcSEcCtD
Estazolam—GABRA1—Transmission across Chemical Synapses—MDM2—hematologic cancer	3.74e-05	0.000416	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.72e-05	0.000414	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.7e-05	0.000412	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—MTR—hematologic cancer	3.68e-05	0.000409	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—EP300—hematologic cancer	3.66e-05	0.000407	CbGpPWpGaD
Estazolam—Nausea—Epirubicin—hematologic cancer	3.64e-05	6.43e-05	CcSEcCtD
Estazolam—Vomiting—Doxorubicin—hematologic cancer	3.6e-05	6.37e-05	CcSEcCtD
Estazolam—GABRB2—Neuronal System—MDM2—hematologic cancer	3.59e-05	0.000399	CbGpPWpGaD
Estazolam—Rash—Doxorubicin—hematologic cancer	3.57e-05	6.31e-05	CcSEcCtD
Estazolam—Dermatitis—Doxorubicin—hematologic cancer	3.57e-05	6.31e-05	CcSEcCtD
Estazolam—Headache—Doxorubicin—hematologic cancer	3.55e-05	6.27e-05	CcSEcCtD
Estazolam—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	3.5e-05	0.000389	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—MDM2—hematologic cancer	3.48e-05	0.000387	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	3.47e-05	0.000385	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—CREB1—hematologic cancer	3.46e-05	0.000385	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.43e-05	0.000382	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—BRAF—hematologic cancer	3.42e-05	0.00038	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—MDM2—hematologic cancer	3.42e-05	0.00038	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.42e-05	0.00038	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.4e-05	0.000378	CbGpPWpGaD
Estazolam—Nausea—Doxorubicin—hematologic cancer	3.36e-05	5.95e-05	CcSEcCtD
Estazolam—GABRA2—Neuronal System—MDM2—hematologic cancer	3.36e-05	0.000374	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—MDM2—hematologic cancer	3.34e-05	0.000371	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.32e-05	0.000369	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.3e-05	0.000367	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—MDM2—hematologic cancer	3.28e-05	0.000365	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.27e-05	0.000364	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.26e-05	0.000362	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.25e-05	0.000362	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.24e-05	0.00036	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.21e-05	0.000357	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.2e-05	0.000356	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.18e-05	0.000354	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.18e-05	0.000354	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.16e-05	0.000352	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.12e-05	0.000347	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—HRAS—hematologic cancer	3.11e-05	0.000346	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.11e-05	0.000345	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ALB—hematologic cancer	3.06e-05	0.000341	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.05e-05	0.000339	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.01e-05	0.000334	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—HRAS—hematologic cancer	2.98e-05	0.000331	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	2.97e-05	0.00033	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—MDM2—hematologic cancer	2.87e-05	0.000319	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—HRAS—hematologic cancer	2.84e-05	0.000316	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—AKT1—hematologic cancer	2.75e-05	0.000305	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.73e-05	0.000304	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.71e-05	0.000302	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.7e-05	0.0003	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.66e-05	0.000295	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.57e-05	0.000286	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ALB—hematologic cancer	2.52e-05	0.000281	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.49e-05	0.000277	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.49e-05	0.000276	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.45e-05	0.000272	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.43e-05	0.00027	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.41e-05	0.000268	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	2.4e-05	0.000267	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.39e-05	0.000266	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.39e-05	0.000266	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.35e-05	0.000261	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—HRAS—hematologic cancer	2.34e-05	0.00026	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—HRAS—hematologic cancer	2.3e-05	0.000256	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.27e-05	0.000252	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.23e-05	0.000248	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.2e-05	0.000245	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.2e-05	0.000245	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.17e-05	0.000241	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.13e-05	0.000237	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.12e-05	0.000236	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.11e-05	0.000235	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.08e-05	0.000231	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ALB—hematologic cancer	2.06e-05	0.00023	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.05e-05	0.000228	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ALB—hematologic cancer	2.03e-05	0.000225	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.99e-05	0.000221	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.98e-05	0.00022	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—HRAS—hematologic cancer	1.97e-05	0.000219	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.94e-05	0.000216	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—HRAS—hematologic cancer	1.91e-05	0.000213	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—HRAS—hematologic cancer	1.88e-05	0.000209	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—FTCD—hematologic cancer	1.86e-05	0.000207	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PHYH—hematologic cancer	1.86e-05	0.000207	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GMPS—hematologic cancer	1.86e-05	0.000207	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—HRAS—hematologic cancer	1.84e-05	0.000205	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—HRAS—hematologic cancer	1.83e-05	0.000204	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.81e-05	0.000202	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—HRAS—hematologic cancer	1.8e-05	0.0002	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.7e-05	0.000189	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.7e-05	0.000189	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—HRAS—hematologic cancer	1.57e-05	0.000175	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—DCK—hematologic cancer	1.49e-05	0.000165	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.49e-05	0.000165	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ASNS—hematologic cancer	1.49e-05	0.000165	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HDC—hematologic cancer	1.41e-05	0.000157	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CDA—hematologic cancer	1.29e-05	0.000143	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PC—hematologic cancer	1.24e-05	0.000138	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.2e-05	0.000133	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GBA—hematologic cancer	1.2e-05	0.000133	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTAP—hematologic cancer	1.1e-05	0.000122	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—FHL2—hematologic cancer	9.77e-06	0.000109	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AGRN—hematologic cancer	9.58e-06	0.000107	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—IDH2—hematologic cancer	9.08e-06	0.000101	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HMMR—hematologic cancer	9.08e-06	0.000101	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.54e-06	9.5e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CA9—hematologic cancer	8.31e-06	9.24e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ACP5—hematologic cancer	8.31e-06	9.24e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.2e-06	9.12e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—IDH1—hematologic cancer	7.81e-06	8.69e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.72e-06	8.59e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TXN—hematologic cancer	7.72e-06	8.59e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.72e-06	8.59e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.56e-06	8.41e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.26e-06	8.08e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.06e-06	7.86e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.06e-06	7.86e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.88e-06	7.66e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NUP98—hematologic cancer	6.67e-06	7.41e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.47e-06	7.2e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.47e-06	7.2e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NUP214—hematologic cancer	6.43e-06	7.15e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTR—hematologic cancer	6.3e-06	7e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.3e-06	7e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ENO2—hematologic cancer	6.17e-06	6.87e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.99e-06	6.66e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SDC1—hematologic cancer	5.85e-06	6.51e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NQO1—hematologic cancer	4.98e-06	5.53e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CD44—hematologic cancer	4.98e-06	5.53e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYCS—hematologic cancer	4.71e-06	5.24e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.68e-06	5.2e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.15e-06	4.62e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.93e-06	4.37e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.81e-06	4.24e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.81e-06	4.24e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.37e-06	3.75e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.83e-06	3.15e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.63e-06	2.92e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.49e-06	2.77e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALB—hematologic cancer	2.46e-06	2.73e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.35e-06	2.61e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.17e-06	2.41e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTEN—hematologic cancer	1.88e-06	2.09e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—EP300—hematologic cancer	1.79e-06	1.99e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.32e-06	1.47e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AKT1—hematologic cancer	1.08e-06	1.2e-05	CbGpPWpGaD
